Urology treats urinary tract diseases in all genders and male reproductive issues, covering the kidneys, bladder, prostate, urethra, from infections to complex cancers.
Send us all your questions or requests, and our expert team will assist you.
Robotic Urology is a therapeutic modality, a sophisticated method of treatment rather than a disease entity itself. Consequently, the symptoms and risk factors relevant to this category are those associated with the underlying urological pathologies—predominantly malignancies and complex structural defects—that necessitate such high-level intervention. Patients who present to the Department of Urology at Liv Hospital for robotic consultation typically do so because they have been diagnosed with conditions affecting the prostate, kidneys, bladder, or adrenal glands. Understanding the diverse and often subtle symptomatology of these conditions is the first step toward early diagnosis, a cornerstone of successful robotic outcomes. The decision to employ a robotic approach is usually driven by the need to address these severe conditions while mitigating the risks associated with both the disease progression and the physiological impact of treatment.
The risk factors in this context are twofold: the epidemiological factors predisposing patients to the diseases, and the patient-specific factors that make them ideal candidates for a robotic approach over traditional open surgery.
Because many of these conditions are silent in their early, most treatable stages, screening plays a pivotal role in the path to robotic surgery. The Prostate-Specific Antigen (PSA) test, while not diagnostic of cancer itself, serves as a crucial red flag that prompts further investigation. Similarly, the increasing use of abdominal imaging for unrelated complaints has led to a rise in the detection of small, incidental kidney tumors (“incidentalomas”) that are ideally suited for robotic partial nephrectomy. Recognizing risk factors enables targeted screening, ensuring that if pathology is present, it is identified when robotic intervention offers the highest probability of cure with the least impact on the patient’s life.
Send us all your questions or requests, and our expert team will assist you.
Painless blood in the urine, or hematuria, is the most common warning sign of bladder and kidney cancer. Unlike infections or stones, which usually cause pain, cancer often bleeds without causing discomfort. Therefore, any instance of blood in the urine requires immediate medical investigation to rule out malignancy.
No, an elevated PSA can be caused by benign conditions such as infection (prostatitis) or benign enlargement of the prostate (BPH). It is a non-specific marker. If PSA is elevated, further tests like MRI and biopsy are needed to confirm if cancer is present. Even if cancer is found, some cases may be monitored rather than treated surgically.
No, the majority of early-stage kidney tumors cause no symptoms at all. They are often discovered “accidentally” during ultrasounds or CT scans performed for other reasons. This early detection is beneficial, as these small tumors are usually ideal candidates for robotic partial nephrectomy, which saves the kidney.
n many cases, robotic surgery is actually safer forIs obesity a barrier to having robotic surgery? obese patients than open surgery. Open surgery in patients with significant body fat requires extensive incisions that are prone to infection and healing issues. The robotic ports are small and bypass the layers of tissue, allowing the surgeon to work internally with the same precision as in a thin patient.
Smoking is a major cause of bladder and kidney cancer. The kidneys filter toxins from tobacco smoke and concentrate them in the urine, where they damage the lining of the bladder. Quitting smoking is the most effective lifestyle change to prevent these cancers and the subsequent need for surgical removal.
Your Comparison List (you must select at least 2 packages)
